Prysmian: model coverage done, runner holds but technicals are sending warnings
Prysmian is at week 22 of a trade up +61% from entry: all 3 model windows are behind us, coverage is complete, and the remaining 40% runs with a trailing stop. But the last few weeks show a technical picture that is gradually deteriorating.
Plug Power: all 3 targets hit, runner rides with stop in profit
Plug Power has completed model coverage at week 11: all 3 statistical targets hit, trade up 44%, structural stop protecting the gain. The 40% runner is still in play.
Palantir at week 19: a technical bounce swallowed in a single session
At week 19 of the sell signal, Palantir erased the prior week's technical bounce in a single 13% drop. The bearish front holds, but MACD is converging and CMF stays in neutral territory.
Phio Pharmaceuticals: the rebound breaks down, selling pressure returns
At week 6 of the sell signal, Phio Pharmaceuticals closes down 4.5% after 2 weeks of rebound. Sellers return dominant at 89% of volume, and CMF deteriorates. Our model flags elevated-risk conditions.
The decline loses momentum: CMF turns positive and momentum near zero
Procter & Gamble is at week 12 of a sell signal. Over the past 4 weeks the decline has progressively lost momentum: CMF back in positive territory, momentum near zero, MACD histogram sharply converging. The confirmation week closed up 2.1%.
Pfizer — four weeks of waiting: the decline has not yet confirmed
Pfizer is at week 4 of a sell signal that has not yet confirmed: three sideways weeks after the initial drop, with a daily double bottom in the 25 area and CMF still negative but gradually recovering.